Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial lipopolysaccharide (LPS) and outer membrane porins (OMPs) are fundamental components of the Gram-negative bacterial cell envelope that define the interface between the bacterium and its environment. LPS, located in the outer leaflet of the outer membrane, consists of lipid A, a core oligosaccharide, and an O-antigen; it serves as a critical permeability barrier against hydrophobic antibiotics and detergents while acting as a potent endotoxin that triggers host immune responses via the TLR4 pathway [PMID: 12948867, PMID: 11701119]. Outer membrane porins are water-filled protein channels that allow the passive diffusion of essential nutrients and are the primary route of entry for many hydrophilic antibiotics, such as beta-lactams and fluoroquinolones [PMID: 12948867]. These structures are vital for bacterial survival, and their modification—such as lipid A remodeling or porin downregulation—is a major mechanism of multidrug resistance in pathogens like Pseudomonas aeruginosa and Acinetobacter baumannii [PMID: 10449201]. Therapeutic strategies targeting these components include polymyxins, which disrupt LPS integrity, and novel inhibitors that block LPS transport or assembly [PMID: 18549758, PMID: 29439114]. Understanding the interplay between LPS and porins is essential for developing effective treatments against resistant Gram-negative infections and managing the systemic inflammatory consequences of endotoxin release during sepsis.
Direct binding to the lipid A component of LPS, displacing calcium and magnesium ions, which destabilizes the outer membrane and leads to cell lysis [PMID: 18549758]; passive or facilitated diffusion of hydrophilic antibiotics through porin channels to reach the periplasmic space or cytoplasm [PMID: 12948867]; inhibition of the Lpt (Lipopolysaccharide transport) protein complex, preventing LPS from reaching the outer membrane [PMID: 29439114].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial lipopolysaccharide and outer membrane porins (LPS and OMPs).